Eli Lilly & Co.

Oncology and Haematologic Malignancies

Clinical research includes breast cancer, non-small cell lung cancer, prostate cancer, colorectal cancer, pancreatic cancer, ovarian cancer, urothelial carcinoma, thyroid cancer, and other solid tumours, with additional studies in glioma, neuroblastoma, and advanced hematologic malignancies.

  • Metastatic and advanced solid tumours
  • Genomically defined cancers
  • Breast, lung, prostate, and gastrointestinal cancers
  • Brain tumours and paediatric oncology

Research activity also covers tumour subtypes linked to KRAS, RET, FGFR3, IDH1, and IDH2 alterations.

Metabolic, Cardiovascular, and Renal Disorders

Studies focus on type 2 diabetes, type 1 diabetes, obesity, overweight, hypertension, atherosclerotic cardiovascular disease, heart failure with preserved ejection fraction, peripheral arterial disease, and chronic kidney disease.

  • Diabetes and beta-cell preservation
  • Weight management and obesity-related disease
  • Cardiovascular risk reduction
  • Kidney function and renal impairment

Additional interest includes lipoprotein(a) and broader lipid disorders in people at elevated cardiovascular risk.

Immunology, Inflammation, and Autoimmune Disease

The sponsor funds trials in rheumatoid arthritis, juvenile idiopathic arthritis, uveitis, atopic dermatitis, alopecia areata, hidradenitis suppurativa, Crohn’s disease, ulcerative colitis, and other inflammatory bowel diseases.

  • Inflammatory arthritis
  • Skin and hair autoimmune conditions
  • Ocular inflammation
  • Gastrointestinal immune-mediated disease

Research also extends to connective tissue diseases and immune system diseases across adult and paediatric populations.

Neurology, Neurodegeneration, and Migraine

Clinical programmes address Alzheimer disease, dementia, relapsing multiple sclerosis, sporadic amyotrophic lateral sclerosis, chronic migraine, and episodic migraine, alongside broader central nervous system diseases and neurocognitive disorders.

  • Alzheimer’s disease and cognitive decline
  • Multiple sclerosis
  • Motor neuron disease
  • Paediatric and adolescent migraine

Research interest includes disorders affecting the nervous system and neurodegenerative diseases across different stages of life.

Respiratory, Sleep, Pain, and Other Chronic Conditions

Additional studies cover asthma, chronic rhinosinusitis with nasal polyps, obstructive sleep apnea, osteoarthritis, chronic low back pain, neuropathic pain, stress urinary incontinence, nausea, and vomiting.

  • Airway and allergic disease
  • Sleep-disordered breathing
  • Musculoskeletal pain and joint disease
  • Urological symptoms and supportive care

Trial activity also includes chronic pain syndromes and other symptomatic conditions affecting daily function.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Efficacy and Safety of Brenipatide (LY3537031) in Adults with Irritable Bowel Syndrome‑Constipation (IBS‑C) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

    Not yet recruiting

    2 1
    Investigated Drugs:
    Belgium Spain
  • Effect of Lepodisiran on Coronary Plaque in Adults with Elevated Lipoprotein(a) and Established Atherosclerotic Cardiovascular Disease or High Risk for First Event

    Not yet recruiting

    3 1
    Investigated Drugs:
    Czechia Hungary The Netherlands Spain
  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    Belgium Germany Hungary Italy Poland
  • Study of Peresolimab for Adults with Moderate to Severe Rheumatoid Arthritis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Greece Hungary Italy Poland Spain
  • Study of LY3454738 for Treating Moderate-to-Severe Atopic Dermatitis in Adults

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Hungary Italy Poland
  • A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

    Not recruiting

    3 1
    Investigated Diseases:
    Austria Belgium Czechia Denmark France Germany +8